Research programme: hepatic glucose output inhibitors - Metabolex
Alternative Names: hepatic glucose output inhibitors research programme - Metabolex; MBX 668Latest Information Update: 23 Mar 2007
At a glance
- Originator Metabolex
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 23 Mar 2007 Discontinued - Preclinical for Diabetes mellitus in USA (PO)
- 21 Aug 2003 Metabolex is screening preclinical candidates of the programme
- 05 Jul 2001 Preclinical development for Diabetes mellitus in USA (PO)